NCT06756009

Brief Summary

This study investigates the correlation between ocular biological characteristics and overall conditions before and after liver transplantation by collecting ocular biological characteristics. Explore whether it is possible to construct a clinical prediction model for liver transplantation by incorporating ocular biometric features, in order to optimize disease management before and after liver transplantation.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Mar 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress87%
Mar 2022Dec 2026

Study Start

First participant enrolled

March 1, 2022

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

December 25, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 1, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Expected
Last Updated

January 1, 2025

Status Verified

August 1, 2024

Enrollment Period

3.8 years

First QC Date

December 25, 2024

Last Update Submit

December 25, 2024

Conditions

Keywords

Diagnostic Techniques, Ophthalmologicalliver transplantationLiver Cirrhoses

Outcome Measures

Primary Outcomes (1)

  • The performance of predicting the prognosis of liver transplantation

    Based on the outcomes of early graft dysfunction and 1-year graft survival rate, the area under the receiver operating characteristic curve, specificity, and sensitivity of the model

    1 week and 1 year after liver transplantation

Secondary Outcomes (1)

  • The performance of the model in assessing the severity of liver disease

    1 year

Study Arms (3)

preoperative group

Registered liver transplant patients from preoperative to postoperative follow-up

Diagnostic Test: Ophthalmic examinationDiagnostic Test: General Condition Examination

Simple postoperative group

Follow up from after liver transplantation

Diagnostic Test: Ophthalmic examinationDiagnostic Test: General Condition Examination

Healthy control group

Healthy individuals without liver disease

Diagnostic Test: Ophthalmic examinationDiagnostic Test: General Condition Examination

Interventions

Ophthalmic examinationDIAGNOSTIC_TEST

Various ophthalmic examination modalities, including slit lamp photography, fundus photography, optical coherence tomography imaging and optical coherence tomography angiography, etc.

Healthy control groupSimple postoperative grouppreoperative group

Various general condition examination, including blood pressure measurement, blood glucose testing, blood routine examination, coagulation function test, liver function test, etc.

Healthy control groupSimple postoperative grouppreoperative group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The liver transplant population was recruited from individuals who went to cooperative medical unit for liver transplant registration, while normal individuals were recruited from the project responsible unit.

You may qualify if:

  • Age greater than or equal to 18 years old;
  • Late stage liver disease patients waiting for liver transplantation treatment, as well as patients with varying degrees of cirrhosis;
  • Can collect complete basic demographic information, liver function blood test indicators, liver pathology and imaging examination results;
  • Can cooperate with eye OCT, OCTA and other examinations, and obtain qualified examination parameters;
  • Voluntarily follow the clinical trial protocol and sign the informed consent form.

You may not qualify if:

  • History of other organ transplant surgeries;
  • History of intraocular laser treatment, medication injection, and surgery;
  • History of high myopia, glaucoma, and retinal choroidal related eye diseases;
  • History of major systemic diseases other than liver disease;
  • Individuals whose overall body and eye conditions cannot cooperate with eye examinations.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhongshan Ophthalmic Center, Sun Yat-sen University

Guangzhou, Guangdong, 510060, China

RECRUITING

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof.

Study Record Dates

First Submitted

December 25, 2024

First Posted

January 1, 2025

Study Start

March 1, 2022

Primary Completion

December 30, 2025

Study Completion (Estimated)

December 30, 2026

Last Updated

January 1, 2025

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations